The potential of CRISPR/Cas9 gene editing as a treatment strategy for inherited diseases

SA Abdelnour, L Xie, AA Hassanin, E Zuo… - Frontiers in cell and …, 2021 - frontiersin.org
Clustered regularly interspaced short palindromic repeats (CRISPR) is a promising
innovative technology for genomic editing that offers scientists the chance to edit DNA …

How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques

SB Wortmann, MM Oud, M Alders… - Journal of Inherited …, 2022 - Wiley Online Library
Exome sequencing (ES) in the clinical setting of inborn metabolic diseases (IMDs) has
created tremendous improvement in achieving an accurate and timely molecular diagnosis …

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2. 0): a policy statement of the American …

SS Kalia, K Adelman, SJ Bale, WK Chung, C Eng… - Genetics in …, 2017 - nature.com
Disclaimer: These recommendations are designed primarily as an educational resource for
medical geneticists and other healthcare providers to help them provide quality medical …

Targeted mRNA therapy for ornithine transcarbamylase deficiency

MG Prieve, P Harvie, SD Monahan, D Roy, AG Li… - Molecular Therapy, 2018 - cell.com
We describe a novel, two-nanoparticle mRNA delivery system and show that it is highly
effective as a means of intracellular enzyme replacement therapy (i-ERT) using a murine …

Hyperammonemia in inherited metabolic diseases

GS Ribas, FF Lopes, M Deon, CR Vargas - Cellular and Molecular …, 2022 - Springer
Ammonia is a neurotoxic compound which is detoxified through liver enzymes from urea
cycle. Several inherited or acquired conditions can elevate ammonia concentrations in …

[HTML][HTML] Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders

L Rodríguez-Pombo, MJ de Castro-López… - International Journal of …, 2024 - Elsevier
Rare diseases are infrequent, but together they affect up to 6–10% of the world's population,
mainly children. Patients require precise doses and strict adherence to avoid metabolic or …

Ornithine transcarbamylase–From structure to metabolism: An update

M Couchet, C Breuillard, C Corne, J Rendu… - Frontiers in …, 2021 - frontiersin.org
Ornithine transcarbamylase (OTC; EC 2.1. 3.3) is a ubiquitous enzyme found in almost all
organisms, including vertebrates, microorganisms, and plants. Anabolic, mostly trimeric …

Medium‐chain Acyl‐COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment

E Mason, CCT Hindmarch… - … diabetes & metabolism, 2023 - Wiley Online Library
Abstract Introduction Medium‐Chain Acyl‐CoA Dehydrogenase Deficiency (MCADD) is the
most common inherited metabolic disorder of β‐oxidation. Patients with MCADD present …

Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution

M Cabanes-Creus, RG Navarro, SHY Liao… - … Therapy Methods & …, 2023 - cell.com
Recent clinical successes have intensified interest in using adeno-associated virus (AAV)
vectors for therapeutic gene delivery. The liver is a key clinical target, given its critical …

Challenges in diagnosing and managing adult patients with urea cycle disorders

KM Stepien, T Geberhiwot… - Journal of inherited …, 2019 - Wiley Online Library
Urea cycle disorders (UCD) are a group of rare inherited metabolic conditions of amino acid
catabolism caused by an enzyme deficiency within the hepatic ammonia detoxification …